KRT17 Antikörper (AA 1-432)
Kurzübersicht für KRT17 Antikörper (AA 1-432) (ABIN561630)
Target
Alle KRT17 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-432
-
Verwendungszweck
- Mouse monoclonal antibody raised against a full length recombinant KRT17.
-
Sequenz
- MTTSIRQFTS SSSIKGSSGL GGGSSRTSCR LSGGLGAGSC RLGSAGGLGS TLGGSSYSSC YSFGSGGGYG SSFGGVDGLL AGGEKATMQN LNDRLASYLD KVRALEEANT ELEVKIRDWY QRQAPGPARD YSQYYRTIEE LQNKILTATV DNANILLQID NARLAADDFR TKFETEQALR LSVEADINGL RRVLDELTLA RADLEMQIEN LKEELAYLKK NHEEEMNALR GQVGGEINVE MDAAPGVDLS RIPNEMRDQY EKMAEKNRKD AEDWFFSKTE ELNREVATNS ELVQSGKSEI SELRRTMQAL EIELQSQLSM KASLEGNLAE TENRYCVQLS QIQGLIGSVE EQLAQLRCEM EQQNQEYKIL LDVKTRLEQE IATYRRLLEG EDAHLTQYKK EPVTTRQVRT IVEEVQDGKV ISSREQVHQT TR
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- KRT17 (AAH00159, 1 a.a. ~ 432 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis." in: BMC cancer, Vol. 7, pp. 55, (2007) (PubMed).
: "
-
Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis." in: BMC cancer, Vol. 7, pp. 55, (2007) (PubMed).
-
- KRT17 (Keratin 17 (KRT17))
-
Andere Bezeichnung
- KRT17
-
Hintergrund
-
Full Gene Name: keratin 17
Synonyms: K17,PC,PC2,PCHC1 -
Gen-ID
- 3872
Target
-